Impact of immunoglobulin subtype on the frequency and severity of renal failure in multiple myeloma: a real-world retrospective study
Journal of Current Hematology & Oncology Research · 18.05.2026 · 4 (2) · 57-62
DOI: 10.51271/jchor-0083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Current Hematology & Oncology Research, online erschienen am 18.05.2026. Verfasst von Aslı Odabaşı Giden.
Abstract (Originalsprache)
Aims
The aim of this study was to evaluate the association between immunoglobulin subtypes and the development of renal failure in patients with multiple myeloma.
Methods
This retrospective cross-sectional observational study included 52 patients diagnosed with multiple myeloma between January 2020 and May 2025. Patients were classified according to immunoglobulin subtype (IgG, IgA, and light chain). Renal failure was defined as an estimated glomerular filtration rate
Zitieren
APA
Giden, A. O. (2026). Impact of immunoglobulin subtype on the frequency and severity of renal failure in multiple myeloma: a real-world retrospective study. Journal of Current Hematology & Oncology Research, 4(2), 57-62. https://doi.org/10.51271/jchor-0083
Vancouver
Giden AO. Impact of immunoglobulin subtype on the frequency and severity of renal failure in multiple myeloma: a real-world retrospective study. Journal of Current Hematology & Oncology Research. 2026;4(2):57-62. doi:10.51271/jchor-0083
BibTeX
@article{Giden2026,
author = {Giden, Aslı Odabaşı},
title = {Impact of immunoglobulin subtype on the frequency and severity of renal failure in multiple myeloma: a real-world retrospective study},
journal = {Journal of Current Hematology & Oncology Research},
year = {2026},
volume = {4},
number = {2},
pages = {57--62},
doi = {10.51271/jchor-0083}
}
EUVIMED